Fractyl Health, Inc.
GUTS
$1.92
$0.084.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -94.26% | -79.83% | -132.97% | -96.68% | -127.26% |
| Total Depreciation and Amortization | 118.09% | 170.30% | 422.29% | 454.92% | 200.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -98.24% |
| Total Other Non-Cash Items | 1,306.93% | 497.87% | 432.43% | -168.56% | -157.48% |
| Change in Net Operating Assets | -17.20% | 153.39% | -0.49% | 1,002.53% | 798.14% |
| Cash from Operations | -45.59% | -56.25% | -136.70% | -203.10% | -187.27% |
| Capital Expenditure | 52.82% | 38.12% | 14.07% | -521.48% | -892.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 52.82% | 38.12% | 14.07% | -521.48% | -892.86% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -428.57% | -273.79% | -258.54% | -133.75% | -6.33% |
| Issuance of Common Stock | -22.92% | -97.82% | -99.34% | 473,840.91% | 2,082,120.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | 100.00% | -196.37% | -771.25% |
| Cash from Financing | -20.67% | -98.54% | -99.69% | 269.29% | 259.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -117.58% | -207.66% | -184.97% | 515.97% | 451.24% |